PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Promising role of filgrastim and alpha-tocopherol succinate in amelioration of gastrointestinal acute radiation syndrome (GI-ARS) in mice.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31350581 ↗2019Reported benefit

Promising role of filgrastim and alpha-tocopherol succinate in amelioration of gastrointestinal acute radiation syndrome (GI-ARS) in mice.

MouseRadiationMalen = Mice randomly allocated into 5 groups; group sizes not stat…Subcutaneous injectionFilgrastim 5 microg/kg/day; alpha-tocopherol succinate 400…Alpha-tocopherol succinate given 1 day before irradiation; filgrastim started 1…

Model: Gastrointestinal acute radiation syndrome induced by 10 Gy whole-body gamma irradiation

Alpha-tocopherol succinate alone reduced malondialdehyde and normalised glutathione, whereas filgrastim alone did not affect these oxidative markers; both lowered myeloperoxidase and IL-1beta. The combination markedly increased glutathione, raised serum citrulline by 94%, reduced epithelial damage…

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.